MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
195.69%
Quick Ratio
195.69%
Cash Ratio
154.08%
Debt to Asset Ratio
137.40%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses & other current...
    • Marketable securities
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
6,660,170
4,917,796
4,422,838
8,389,486
Marketable securities
701,085
1,405,057
5,696,386
3,973,090
Prepaid expenses & other current assets
1,097,664
734,407
683,948
1,098,429
Total current assets
8,458,919
7,057,260
10,803,172
13,461,005
Property and equipment, net
24,271
28,022
31,875
35,977
Operating lease right-of-use assets
38,242
56,868
75,595
93,090
Deferred offering costs
54,827
54,827
88,431
-
Other assets
26,090
26,090
36,738
36,738
Total assets
8,602,349
7,223,067
11,035,811
13,626,810
Accounts payable and accrued expenses
4,282,797
3,718,290
4,423,048
3,946,018
Operating lease liabilities, current
39,715
59,076
78,539
93,954
Total current liabilities
4,322,512
3,777,366
4,501,587
4,039,972
Warrant liability
7,497,089
-
-
-
Total liabilities
11,819,601
3,777,366
4,501,587
4,039,972
Common stock (25,000,000 authorized at june 30, 2026 and december 31, 2025 .0001 par value) (12,759,146 and 11,254,697 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively)
1,276
1,125
1,125
1,104
Additional paid-in capital
100,367,581
99,954,439
99,652,724
98,616,239
Accumulated other comprehensive (loss) income
-39,759
-35,637
25,430
40,333
Accumulated deficit
-103,546,350
-96,474,226
-93,145,055
-89,070,838
Total stockholders (deficit) equity
-3,217,252
3,445,701
6,534,224
9,586,838
Total liabilities and stockholders (deficit) equity
8,602,349
7,223,067
11,035,811
13,626,810
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$6,660,170 (9.88%↑ Y/Y)Prepaid expenses & othercurrent assets$1,097,664 (-15.50%↓ Y/Y)Marketable securities$701,085 (-92.88%↓ Y/Y)Total current assets$8,458,919 (-50.82%↓ Y/Y)Deferred offering costs$54,827 Operating leaseright-of-use assets$38,242 (-73.30%↓ Y/Y)Other assets$26,090 (-28.98%↓ Y/Y)Property and equipment,net$24,271 (-38.59%↓ Y/Y)Total assets$8,602,349 (-50.62%↓ Y/Y)Accumulated deficit-$103,546,350 (-21.97%↓ Y/Y)Accumulated othercomprehensive (loss) income-$39,759 (-182.76%↓ Y/Y)Total liabilities andstockholders (deficit)...$8,602,349 (-50.62%↓ Y/Y)Total stockholders(deficit) equity-$3,217,252 (-125.69%↓ Y/Y)Additional paid-in capital$100,367,581 (3.08%↑ Y/Y)Common stock(25,000,000 authorized at...$1,276 (18.37%↑ Y/Y)Total liabilities$11,819,601 (141.32%↑ Y/Y)Warrant liability$7,497,089 Total currentliabilities$4,322,512 (-11.50%↓ Y/Y)Accounts payable andaccrued expenses$4,282,797 (-9.89%↓ Y/Y)Operating leaseliabilities, current$39,715 (-69.80%↓ Y/Y)

Lantern Pharma Inc. (LTRN)

Lantern Pharma Inc. (LTRN)